1
|
Demeester SR: Epidemiology and biology of
esophageal cancer. Gastrointest Cancer Res. 3(Suppl): S2–S5.
2009.PubMed/NCBI
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Medina PP and Slack FJ: microRNAs and
cancer: An overview. Cell Cycle. 7:2485–2492. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Guo Y, Chen Z, Zhang L, Zhou F, Shi S,
Feng X, Li B, Meng X, Ma X, Luo M, et al: Distinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hu Y, Correa AM, Hoque A, Guan B, Ye F,
Huang J, Swisher SG, Wu TT, Ajani JA and Xu XC: Prognostic
significance of differentially expressed miRNAs in esophageal
cancer. Int J Cancer. 128:132–143. 2011. View Article : Google Scholar
|
8
|
Li X, Wainscott C and Xi Y: MicroRNA
provides insight into understanding esophageal cancer. Thorac
Cancer. 2:134–142. 2011. View Article : Google Scholar
|
9
|
Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen
X, Gao Z, Xin J, Zhou S, Zhou Z, et al: MiR-203 suppresses tumor
growth and invasion and down-regulates miR-21 expression through
repressing Ran in esophageal cancer. Cancer Lett. 342:121–129.
2014. View Article : Google Scholar
|
10
|
Qin C, Huang RY and Wang ZX: Potential
role of miR-100 in cancer diagnosis, prognosis, and therapy. Tumour
Biol. 36:1403–1409. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Sun J, Chen Z, Tan X, Zhou F, Tan F, Gao
Y, Sun N, Xu X, Shao K and He J: MicroRNA-99a/100 promotes
apoptosis by targeting mTOR in human esophageal squamous cell
carcinoma. Med Oncol. 30:4112013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Laganà A, Forte S, Russo F, Giugno R,
Pulvirenti A and Ferro A: Prediction of human targets for
viral-encoded microRNAs by thermodynamics and empirical
constraints. J RNAi Gene Silencing. 6:379–385. 2010.PubMed/NCBI
|
13
|
Veksler-Lublinsky I, Shemer-Avni Y, Kedem
K and Ziv-Ukelson M: Gene bi-targeting by viral and human miRNAs.
BMC Bioinformatics. 11:2492010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shi W, Alajez NM, Bastianutto C, Hui AB,
Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, et al:
Significance of Plk1 regulation by miR-100 in human nasopharyngeal
cancer. Int J Cancer. 126:2036–2048. 2010.
|
15
|
Fu HL, Wu P, Wang XF, Wang JG, Jiao F,
Song LL, Xie H, Wen XY, Shan HS, Du YX, et al: Altered miRNA
expression is associated with differentiation, invasion, and
metastasis of esophageal squamous cell carcinoma (ESCC) in patients
from Huaian, China. Cell Biochem Biophys. 67:657–668. 2013.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: A fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhang N, Fu H, Song L, Ding Y, Wang X,
Zhao C and Zhao Y, Jiao F and Zhao Y: MicroRNA-100 promotes
migration and invasion through mammalian target of rapamycin in
esophageal squamous cell carcinoma. Oncol Rep. 32:1409–1418.
2014.PubMed/NCBI
|
18
|
Gebeshuber CA and Martinez J: miR-100
suppresses IGF2 and inhibits breast tumorigenesis by interfering
with proliferation and survival signaling. Oncogene. 32:3306–3310.
2013. View Article : Google Scholar
|
19
|
Bi Y, Jing Y and Cao Y: Overexpression of
miR-100 inhibits growth of osteosarcoma through FGFR3. Tumour Biol.
36:8405–8411. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang
J, Yang J, Liao H and Guo L: Downregulation of HOXA1 gene affects
small cell lung cancer cell survival and chemoresistance under the
regulation of miR-100. Eur J Cancer. 50:1541–1554. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhou HC, Fang JH, Luo X, Zhang L, Yang J,
Zhang C and Zhuang SM: Downregulation of microRNA-100 enhances the
ICMT-Rac1 signaling and promotes metastasis of hepatocellular
carcinoma cells. Oncotarget. 5:12177–12188. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang M, Ren D, Guo W, Wang Z, Huang S, Du
H, Song L and Peng X: Loss of miR-100 enhances migration, invasion,
epithelial-mesenchymal transition and stemness properties in
prostate cancer cells through targeting Argonaute 2. Int J Oncol.
45:362–372. 2014.PubMed/NCBI
|
23
|
Huang JS, Egger ME, Grizzle WE and McNally
LR: MicroRNA-100 regulates IGF1-receptor expression in metastatic
pancreatic cancer cells. Biotech Histochem. 88:397–402. 2013.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Libert F, Parmentier M, Lefort A, Dumont
JE and Vassart G: Complete nucleotide sequence of a putative G
protein coupled receptor: RDC1. Nucleic Acids Res. 18:19171990.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Tarnowski M, Liu R, Wysoczynski M,
Ratajczak J, Kucia M and Ratajczak MZ: CXCR7: A new SDF-1-binding
receptor in contrast to normal CD34+ progenitors is
functional and is expressed at higher level in human malignant
hematopoietic cells. Eur J Haematol. 85:472–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Naumann U, Cameroni E, Pruenster M,
Mahabaleshwar H, Raz E, Zerwes HG, Rot A and Thelen M: CXCR7
functions as a scavenger for CXCL12 and CXCL11. PLoS One.
5:e91752010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Eva C and Sprengel R: A novel putative G
protein-coupled receptor highly expressed in lung and testis. DNA
Cell Biol. 12:393–399. 1993. View Article : Google Scholar : PubMed/NCBI
|
28
|
Miao Z, Luker KE, Summers BC, Berahovich
R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A,
Luker GD, et al: CXCR7 (RDC1) promotes breast and lung tumor growth
in vivo and is expressed on tumor-associated vasculature. Proc Natl
Acad Sci USA. 104:15735–15740. 2007. View Article : Google Scholar : PubMed/NCBI
|
29
|
Sun X, Cheng G, Hao M, Zheng J, Zhou X,
Zhang J, Taichman RS, Pienta KJ and Wang J: CXCL12 / CXCR4 / CXCR7
chemokine axis and cancer progression. Cancer Metastasis Rev.
29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Keeley EC, Mehrad B and Strieter RM: CXC
chemokines in cancer angiogenesis and metastases. Adv Cancer Res.
106:91–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Xue TC, Chen RX, Han D, Chen J, Xue Q, Gao
DM, Sun RX, Tang ZY and Ye SL: Down-regulation of CXCR7 inhibits
the growth and lung metastasis of human hepatocellular carcinoma
cells with highly metastatic potential. Exp Ther Med. 3:117–123.
2012.PubMed/NCBI
|
32
|
Zheng K, Li HY, Su XL, Wang XY, Tian T, Li
F and Ren GS: Chemokine receptor CXCR7 regulates the invasion,
angiogenesis and tumor growth of human hepatocellular carcinoma
cells. J Exp Clin Cancer Res. 29:312010. View Article : Google Scholar : PubMed/NCBI
|
33
|
Tachezy M, Zander H, Gebauer F, von Loga
K, Pantel K, Izbicki JR and Bockhorn M: CXCR7 expression in
esophageal cancer. J Transl Med. 11:2382013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Heckmann D, Maier P, Laufs S, Li L,
Sleeman JP, Trunk MJ, Leupold JH, Wenz F, Zeller WJ, Fruehauf S, et
al: The disparate twins: A comparative study of CXCR4 and CXCR7 in
SDF-1α-induced gene expression, invasion and chemosensitivity of
colon cancer. Clin Cancer Res. 20:604–616. 2014. View Article : Google Scholar
|
35
|
Guillemot E, Karimdjee-Soilihi B, Pradelli
E, Benchetrit M, Goguet-Surmenian E, Millet MA, Larbret F, Michiels
JF, Birnbaum D, Alemanno P, et al: CXCR7 receptors facilitate the
progression of colon carcinoma within lung not within liver. Br J
Cancer. 107:1944–1949. 2012. View Article : Google Scholar : PubMed/NCBI
|